SX-fraction: Promise for novel treatment of type 2 diabetes

doi:10.4239/wjd.v11.i12.572

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4347)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

296

WORD

170

HTML

2384

Figures (1-6)

244

Tables (1-3)

183

Sum=3277

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

494

Download

576

Sum=1070

Dec 15, 2020 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Diabetes. Dec 15, 2020; 11(12): 572-583
Published online Dec 15, 2020. doi: 10.4239/wjd.v11.i12.572

Table 2 Hypoglycemic effect of SX-fraction on patient newly diagnosed with type 2 diabetes

Diagnosis/Prognosis	FBG (mg/dL)	HbA_1c (%)
Initial diagnosis	248	11.5
3^rd month prognosis (with 2.5 mg glyburide and SXF)	80-90	5.2
5^th month prognosis (with 1.25 mg glyburide and SXF)	80-90	N/D
9^th month prognosis (with SXF only)	Approximately 90	5.6

N/D: Not determined. SXF: SX-fraction; FBG: Fasting blood glucose; HbA_1c: Glycosylated hemoglobin A_1c.

Citation: Konno S. SX-fraction: Promise for novel treatment of type 2 diabetes. World J Diabetes 2020; 11(12): 572-583
URL: https://www.wjgnet.com/1948-9358/full/v11/i12/572.htm
DOI: https://dx.doi.org/10.4239/wjd.v11.i12.572